Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
March 9th, 2018
12.9K views
Here we describe a protocol to determine pulmonary fungal burden in mice with invasive aspergillosis by quantification of Gomori's modified methanamine silver staining in histological sections. Use of this method resulted in comparable results with less animals compared to assessment of fungal burden by quantitative PCR of lung fungal DNA.
Overview
This protocol outlines a method for quantifying pulmonary fungal burden in mice with invasive aspergillosis using Gomori's modified methenamine silver staining. The technique allows for the use of existing histological samples, yielding results comparable to quantitative PCR while reducing the number of animals required.
Key Study Components
Area of Science
- Neuroscience
- Microbiology
- Pathology
Background
- Invasive aspergillosis is a significant fungal infection in immunocompromised hosts.
- Quantifying fungal burden is crucial for understanding disease progression and host responses.
- Traditional methods like quantitative PCR can be variable and require more animals.
- Histological analysis provides an alternative with potentially less variability.
Purpose of Study
- To develop a reliable protocol for assessing fungal burden in mouse models.
- To explore host response mechanisms and fungal virulence factors.
- To facilitate research in fungal pathogenesis and related diseases.
Methods Used
- Neutrophil depletion in mice prior to infection.
- Infection with A. fumigatus conidia using a specific delivery method.
- Histological preparation and staining of lung tissues.
- Image analysis to quantify fungal burden from stained sections.
Main Results
- The method demonstrated comparable results to quantitative PCR.
- Utilization of existing samples reduced the number of animals needed.
- Provided insights into the infection dynamics and host-pathogen interactions.
- Potential applicability to other studies involving different pathogens.
Conclusions
- This protocol offers a less variable alternative for quantifying fungal burden.
- It enhances the understanding of invasive aspergillosis and host responses.
- The method can be adapted for various pathogen studies in histological contexts.
Frequently Asked Questions
What is the main advantage of this protocol?
The main advantage is that it allows for the use of existing histological samples, reducing variability and the number of animals needed compared to quantitative PCR.
How does this method contribute to understanding fungal pathogenesis?
It helps elucidate protective and detrimental host responses and key fungal virulence factors in invasive aspergillosis.
Can this method be applied to other pathogens?
Yes, the technique can be adapted for studies involving different pathogens that can be stained within host tissues.
What are the key steps in the infection procedure?
Key steps include neutrophil depletion, infection with conidia, and careful monitoring of the mice during the process.
What imaging techniques are used in this protocol?
Light microscopy is used to obtain images of Gomori's modified methenamine silver-stained slides for analysis.
How is fungal burden quantified?
Fungal burden is quantified through image analysis, adjusting threshold values to accurately represent fungal hyphae in microscopy images.
Executive Industry Relevance
Quantitative histological analysis of lung fungal burden in experimental aspergillosis enables precise assessment of host-pathogen interactions and antifungal efficacy in preclinical models. This approach supports predictive confidence in immune mechanism studies and reduces animal usage, aligning with enterprise R&D efficiency and ethical mandates. Integrating image-based quantification with established molecular assays strengthens decision-making at the target validation and lead optimization stages.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous interrogation of immune protection and fungal virulence mechanisms in vivo.
- Supports functional target validation by quantifying pathogen burden in genetically modified models.
- Facilitates mechanistic de-risking by correlating histological burden with molecular and survival endpoints.
Screening & Assay Development
- Provides standardized, quantitative outputs for benchmarking antifungal interventions.
- Reduces variability compared to DNA-based quantification, enhancing assay reproducibility.
- Prepares validated histological systems for downstream compound screening and efficacy studies.
Translational & Preclinical Research
- Aligns preclinical findings with disease-relevant tissue pathology and immune cell recruitment.
- Enables continuity from discovery through preclinical validation by integrating histological and molecular readouts.
- Supports risk-adjusted advancement decisions based on quantitative burden reduction and survival outcomes.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical validation by providing a quantitative, reproducible measure of fungal burden that complements molecular assays and survival data.
- Discovery Biology: Supports hypothesis testing on immune cell function and antifungal response in vivo.
- Screening: Delivers reproducible, quantitative histological outputs for compound efficacy evaluation.
- Analytics: Enables statistical comparison of fungal burden across experimental groups and interventions.
- Translational Research: Connects tissue-level pathology with molecular and survival endpoints for comprehensive preclinical assessment.
- Enterprise Reuse: Leverages existing histological samples for multiple analyses, maximizing data yield per animal.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune-pathogen studies.
- Operational Value: Standardizes quantification, improves reproducibility, and minimizes animal usage.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in antifungal R&D.
- Portfolio Impact: Enables risk-adjusted prioritization of targets and interventions based on robust preclinical data.
Implementation Considerations
- Requires expertise in histological staining, imaging, and quantitative image analysis.
- Needs access to light microscopy and compatible image processing software.
- Demands cross-team standardization of imaging and thresholding parameters for reproducibility.
- Adaptable to other pathogens and tissue models with clear differential staining.
- Consistency in image acquisition and analysis is critical for reliable cross-study comparisons.
Biopharma FAQs
Why does null hypothesis testing matter for GMS-stained fungal burden quantification?
Null hypothesis testing enables objective assessment of whether observed differences in fungal burden between experimental groups are statistically significant, supporting robust target validation and mechanistic claims.
How does independent variable isolation fit into lung infection quantification workflows?
Isolating variables such as immune cell depletion or antifungal treatment allows teams to attribute changes in GMS-quantified fungal burden directly to specific interventions, clarifying mechanistic pathways in discovery pipelines.
What do quantitative dependent variable measurements enable in this protocol?
Quantitative measurement of GMS-stained area provides reproducible, scalable data for comparing fungal burden across genotypes and treatments, enabling statistical analysis and cross-study benchmarking.
Why are replication requirements critical for cross-functional collaboration in fungal burden studies?
Replication ensures that GMS quantification results are consistent and reliable across experiments and teams, facilitating data integration and collaborative decision-making in multi-site R&D environments.
What statistical analysis capabilities are required before implementing GMS-based quantification?
Teams must be equipped to perform area fraction calculations, threshold standardization, and group comparisons using appropriate statistical tests to ensure data validity and actionable insights for portfolio advancement.
Chapters in this video
0:05
Title
1:04
Aspergillus Fumigatus Conidia Infection
3:09
Mouse Lung Harvest and Preservation
5:09
Light Microscopy Imaging and Fungal Burden Calculation
7:26
Results: Representative Survival, Fungal Burden, and Fungal Clearance in a Mouse Model of Invasive Aspergillus Infection
8:53
Conclusion
